25 Thyrotoxic Cardiomyopathy

@inproceedings{Babenko201225TC,
  title={25 Thyrotoxic Cardiomyopathy},
  author={Alina Yu. Babenko and Alekber A. Bairamov and Elena N Grineva and Eugenia O. Ulupova},
  year={2012}
}
1.1 Thyrotoxicosis and thyrotoxic cardiomyopathy – Current state Thyrotoxicosis is a common syndrome, and according to the Wickham Survey its prevalence is 2% among women and 0.2% in men in the areas with normal iodine consumption. Over the 20-year follow-up the incidence of thyrotoxicosis was 0.8:1000 in women and 0.6:1000 in men (Bird et al,1977). Subclinical thyrotoxicosis (ST) is defined by low or undetectable serum thyrotropin stimulating hormone (TSH) and normal free thyroxin (FT4) and… CONTINUE READING

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 103 REFERENCES

induced cardiac hypertrophy

J. Kohrle
  • J. Endocrinol
  • 1999
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Biochemical basis of thyroid hormone action in the heart.

  • The American journal of medicine
  • 1990
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Subclinical thyroid disease in the elderly.

  • Thyroid : official journal of the American Thyroid Association
  • 1998
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Analisis of contribution of various factors in development and type of remodeling left ventricule at thyreotoxicosis. Bulleten of Almazov Federal Heart, Blood and Endocrinology Centre

A Babenko
  • たечати)
  • 2011

Similar Papers

Loading similar papers…